Element Biosciences

San Diego, United States Founded: 2017 • Age: 9 yrs Unicorn
Benchtop DNA sequencers are developed for research and diagnostic uses.

About Element Biosciences

Element Biosciences is a Healthcare company based in San Diego (United States) founded in 2017 by Michael Previte and Molly He. Benchtop DNA sequencers are developed for research and diagnostic uses. Element Biosciences has raised $853.3 million across 8 funding rounds from investors including Fidelity Investments, Morgan Stanley and Samsung. The company has 447 employees. Element Biosciences has completed 1 acquisition, including Element Biosciences. Element Biosciences was last valued at $1 billion in February 2026. Its chief executive, as recorded, is Molly He. Its website elementbiosciences.com draws about 39 thousand monthly visits. Element Biosciences offers products and services including AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its competitors include 10X Genomics, xMD and Plexigen; 2 of its 3 listed competitors have raised funding.

Company details

Founded in 2017 and based in San Diego, United States, operations are centered in the biotechnology sector with a focus on genomics. Benchtop DNA sequencing technology is provided through the AVITI sequencer, which achieves high data quality via an enhanced contrast-to-noise ratio. Applications are targeted at research and diagnostic markets, supporting advancements in genetic analysis.

  • Headquarters San Diego, United States
  • Employees 447
  • Founders Michael Previte, Molly He
  • Stage Unicorn
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website elementbiosciences.com
  • Social LinkedIn X Facebook YouTube
Key Metrics

Products & Services of Element Biosciences

Element Biosciences offers a comprehensive portfolio of products and services, including AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud.

AVITI24
Sequencing Instrument

Instrument for spatial co-detection of RNA, protein, and morphology in sequencing.

Cloudbreak Sequencing Kits
Reagents and Kits

Kits for DNA and RNA sequencing applications in research.

Trinity Sequencing Kits
Reagents and Kits

Kits that simplify targeted sequencing workflows.

ElemBio Cloud
Software

Software platform for managing sequencing data and analysis.

Apps and channels of Element Biosciences

its YouTube channel Element Biosciences has 482 subscribers and 30 videos.

Element Biosciences
YouTube 482 subscribers 30 videos Science & Technology
Open channel

Videos from Element Biosciences

The most watched videos on Element Biosciences's YouTube channel, Element Biosciences (482 subscribers). Click a video to play it here.

AVITI24™ - Next gen sequencing meets in situ multiomics
6.2K views
Cytoprofiling AVITI24 Teton Detection
2.8K views
Element AVITI™ FIT, a Suite of Products to Empower More Researchers with Flexible Genomic Solutions
1.6K views
Element Biosciences: The Element AVITI™ System
1.5K views

More on Element Biosciences.

Funding Insights of Element Biosciences

Element Biosciences has successfully raised a total of $853.3M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $175 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $853.3M
  • Total Rounds 8
  • Last Round Series E — $175M
  • First Round $224,881

    (Sep 2017)

  • Investors Count 14

All 8 funding rounds of Element Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2026$175MSeries E––
Jul 2024$277MSeries D–Wellington
Jun 2021$276MSeries C–Janus Henderson Investors, Logos
Jun 2020$30MSeries B––
–
Jan 2020$80.3MSeries B–Fidelity Investments, JSCapital
Jun 2019$15MSeries A–Foresite Capital, Venrock
–
Feb 2018$221,507Grant––
Sep 2017$224,881Grant––
Valuation history
DateValuationStage
Premium access

Full valuation and stage history of Element Biosciences

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $1B (Feb 2026). 14 investors in total: 14 institutional.

Investors in Element Biosciences

Element Biosciences has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Morgan Stanley and Samsung.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Multi-stage investment firm invests in healthcare and life sciences companies
foresitecapital.comNew York, United States
Multiple sectors are targeted for venture capital investments.
1934janushenderson.comLondon, United Kingdom
Private equity fund focused on the biotechnology sector
logoscapital.comSan Francisco, United States
Private equity investments are directed toward US-based companies.
meritechcapital.comPalo Alto, United States
Venture capital firm focused on tech sectors
venrock.comPalo Alto, United States
Investment in early-stage startups focusing on healthcare, AI, and industrial technology.
fusionfund.com
Diversified investment management services are provided to institutional clients.
wellington.comBoston, United States
Multi-category electronic products are manufactured globally by the company.
1969samsung.comSuwon-si, South Korea
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms
1946fidelity.comBoston, United States
Diversified asset management services are provided to investors globally.
1937troweprice.comBaltimore, United States
Premium access

Investor details for Element Biosciences

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Element Biosciences

137 people are tracked at Element Biosciences (46 in leadership, 2 in board & advisors, 89 in team); the tracked headcount is 447.

NameRoleGroup
Michael Previte
Co-Founder & CTOLeadership
Molly He
Co-Founder & CEOLeadership
Andrew Price
Vice President Systems IntegrationLeadership
Shawn Levy
Chief Scientific Officer & SVP, ApplicationsLeadership
Brian Stolz
Chief People OfficerLeadership
Amirali Kia
Vp, Artificial Intelligence And Data ScienceLeadership
Kim Morch
Associate Director Of Program ManagementLeadership
Kristina Wheeler
Director, AccountingLeadership
Holly Barnes
Sr. Director Commercial OperationsLeadership
Danae van Oene
Senior Vice President, Global Sales And SupportLeadership
Adeline M.
Director, Surface ChemistryLeadership
Semyon Kruglyak
VP Of InformaticsLeadership
Claudia J.
Vp, SoftwareLeadership
Matthew Byrne
Director, Quality And RegulatoryLeadership
Ryan Lown
Sr. Director, FinanceLeadership
John Dimalanta
Sr. Director Of Global Service & SupportLeadership
Fangfang Hu
Director, Marketing And Business DevelopmentLeadership
Howard Z.
Head Of Business DevelopmentLeadership
Evie Felton
Sr. Director, Commercial MarketingLeadership
Sunny Kim
Director Strategic SourcingLeadership

117 more people are available in the full profile.

Premium access

Complete people profiles for Element Biosciences

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Element Biosciences

Element Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Element Biosciences.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
DNA sequencing technologies are developed for microbiome and genomic applications.
loopgenomics.comSunnyvale, United States2015Feb 2022••••
Premium access

Complete acquisition details for Element Biosciences

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Element Biosciences

5 dated milestones of Element Biosciences across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Element Biosciences is founded.
  2. Funding First funding round of $225K.
  3. Acquisition Acquires Element Biosciences.
  4. Milestone Reaches Unicorn status.
  5. Funding Latest funding round, Series E, of $175.0M.

Competitors of Element Biosciences

Element Biosciences has 3 listed competitors in our database, 2 of them funded. They include 10X Genomics, xMD and Plexigen.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
10xgenomics.com2012Pleasanton, United States$199.9M961
Instrument systems for genomic research and sequencing libraries are developed.
xmddiagnostics.com2015Baltimore, United States$775,000
Laboratory instruments and consumables are developed for life science research.
plexigen.com1999Cary, United States
Offers tools and services for genomics and proteomic testing.
Premium access

Detailed competitors of Element Biosciences

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Element Biosciences

The website of Element Biosciences (elementbiosciences.com) receives about 39.1K visits a month.

  • Monthly visits
    39.1K
Similar websites

Websites whose visitors overlap most with Element Biosciences. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
careers.mrcooper.com
careers.mrcooper.com
100%
#674,473–
careers.racetrac.com
careers.racetrac.com
97%
#323,228–
climatetechlist.com
climatetechlist.com
95%
#437,407–
careers.aspendental.com
careers.aspendental.com
94%
#338,059–
oysterlink.com
93%
190K#299,386View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Element Biosciences

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Element Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Element Biosciences

Premium access

Complete news archive for Element Biosciences

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Element Biosciences

Element Biosciences was founded in 2017.

Element Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Molly He is the CEO of Element Biosciences, as recorded in our data. They have also founded this company.

Element Biosciences is a funded company, having raised a total of $853.3M across 8 funding rounds to date. The company's 1st funding round was a Grant of $224.88K, raised on Sep 2017.

Element Biosciences has 447 employees.

Founded in 2017 and based in San Diego, United States, operations are centered in the biotechnology sector with a focus on genomics. Benchtop DNA sequencing technology is provided through the AVITI sequencer, which achieves high data quality via an enhanced contrast-to-noise ratio. Applications are targeted at research and diagnostic markets, supporting advancements in genetic analysis.

Element Biosciences's top competitors include 10X Genomics, xMD and Plexigen.

Element Biosciences offers AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud.

Element Biosciences has made 1 acquisition, including Element Biosciences.

Element Biosciences has 14 investors. Key investors include Fidelity Investments, Morgan Stanley, Samsung, T. Rowe Price, and HHS.

The valuation of Element Biosciences is $1B as of Feb 2026.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available